1.Clinical efficacy and safety of hypofractionated three-dimensional conformal radiotherapy in the treatment of recurrent nasopharyngeal carcinoma
Bin LONG ; Guanghua ZHOU ; Xinhui YANG ; Xiaoyan SHI ; Jun LONG
Chinese Journal of Radiation Oncology 2019;28(3):173-179
Objective To evaluate the clinical efficacy and safety of the hypofractionated three-dimensional conformal radiotherapy in the treatment of recurrent nasopharyngeal carcinoma.Methods Clinical data of 153 patients with recurrent nasopharyngeal carcinoma admitted to our hospital from 2008 to 2013 undergoing hypofractionated three-dimensional conformal radiotherapy (3 Gy for each time,5 times a week,a total dose of 51-60 Gy,17-20 times/4 weeks) were retrospectively analyzed.The short-and long-term radiation-induced injury,Karnofsky performance score (KPS),short-and long-term clinical efficacy were evaluated.Results For the short-term radiation-induced injury,the incidence of oral mucosa and fatigue significantly differed before and after treatment (both P<0.05).Regarding the long-term radiation-induced injury,the incidence of dry mouth (95.4%) and deafness (51.0%),difficulty in opening mouth (79.1%),maxillofacial fibrosis (33.3%) and radiation-induced encephalopathy (15.0%) significantly differed before and following treatment (all P< 0.05).The actual long-term radiation-induced injury included dry mouth (91.5%),deafness (50.9%),difficulty in opening mouth (76.5%),maxillofacial fibrosis (32.0%) and radiation-induced encephalopathy (14.4%).The number of patients with changes in the KPS scores significantly differed between the end of treatment and 3 months after treatment (P<0.05).The local control rates were 29.4%,68.6%,79.1%,83.7% and 86.9% at 1-,3-,6-,9-and 12-month after corresponding treatment,respectively.The local control rate significantly differed between 1 and 3 months,and between 3 and 6 months after treatment (both P<0.05).The 1-,2-,3-,4-and 5-year survival rates were calculated as 96.1%,80.4%,68.5%,57.9% and 51.1%,respectively.Conclusions Hypofractionated three-dimensional conformal radiotherapy is an efficacious and safe treatment of recurrent nasopharyngeal nasopharyngeal carcinoma,which yields relatively high short-and long-term clinical efficacy,high local control rate and well tolerance by the patients.
2.Effect of TLR1 ,TLR2,TLR6 in PBMC from patients with ovarian cancer on tumor microenvironment
Juan XU ; Jianfang LOU ; Xinhui SHI ; Xing KE ; Shuping ZHANG ; Meng WU ; Ruihong SUN ; Lei HUANG ; Fang WANG
International Journal of Laboratory Medicine 2018;39(5):537-542
Objective To explore the pathogenesis of ovarian cancer by investigating the function of Toll-like receptor 1 (TLR1),TLR2 and TLR6 in peripheral blood mononuclear cell(PBMC) from patients with ovarian cancer.Methods PBMC,SK OV 3 co culture system and anti-TLR1,anti-TLR2,anti-TLR6 mAb blocking experiment were used to explore the relationship between TLR1,TLR2 or TLR6 signaling and inflammation in ovarian cancer.Quantitative real time PCR was used to measure interleukin(IL)-1β,IL-6,IL-8,and tumor necrosises factor(TNF)-α in the PBMC.MyD88,TRAF6,TANK,NF-κB and P-NFκB were observed by Western blotting.Results In the PBMC and SK-OV-3 coculture system,we found the activation of TLR signaling pathways,including significantly increased MyD88,TRAF6,TANK and P-NF-κB levels following cocultured with SK-OV-3 in PBMC from ovarian cancer patients.PBMC derived from ovarian cancer patients led to a increase in IL-1β,IL-6 and IL-8 mRNA levels after 24 hours of co-incubation with SK-OV-3 (Fold=1.74,Fold=1.92,Fold=1.65,P<0.05),though there was no difference of TNF-a mRNA expression.In contrast to the ovarian cancer patients,coculture of PBMC derived from benign diseases controls and healthy normal controls decreased IL-1β at the mRNA level (Fold=0.71,P<0.05;Fold=0.72,P<0.05),furthermore the expression of MyD88,TRAF6,TANK,P-NF-κB,and NF-κB showed no changes.PBMC which treated with anti-TLR1,anti-TLR2 or-TLR6 mAb could inhibite inflammatory IL-1β (Fold=0.16,Fold=0.31,Fold=0.29,P<0.05) and IL-6 (Fold=0.14,Fold=0.20,Fold=0.28,P<0.05).Conclusion TLR1/TLR2/TLR6 in PBMC of ovarian cancer patients participate in the recognition of the factors.
3.Clinical analysis of ubenimex combined with radiotherapy for early nasopharyngeal carcinoma
Bin LONG ; Jiali SU ; Limin LIU ; Xinhui YANG ; Xiaoyan SHI ; Jun LONG ; Shuliang LI ; Guanghua ZHOU
Cancer Research and Clinic 2018;30(6):396-399
Objective To observe the efficacy and adverse reactions of ubenimex combined with radiotherapy for the treatment of early nasopharyngeal carcinoma. Methods A total of 129 patients with early nasopharyngeal carcinoma who were admitted to the 163th Hospital of PLA, the Second Affiliated Hospital of Hunan Normal University from October 2013 to September 2016 were retrospectively analyzed. Three-dimensional conformal radiotherapy was used in the control group and ubenimex combined with three-dimensional conformal radiotherapy was taken in the study group. Radiation injury response, quality of life and therapeutic effects of patients in both groups were observed respectively. Results The fatigue incidence of the study group was lower than that of the control group (57.8 % vs. 75.4 %, χ2= 4.481, P= 0.034). Karnofsky score (χ2=6.345, P=0.042; χ2=6.382, P=0.041, respectively) and weight change (χ2=6.014, P= 0.049; χ2= 6.351, P= 0.042, respectively) had statistical differences in both groups in the end of radiotherapy and 3 months after radiotherapy. 1-year non-distant metastasis survival rate (92.2 %, 59/64) in the study group was significantly higher than that in the control group (80.0 %, 52/65) (χ2=3.989, P=0.046). Conclusion Ubenimex combined with radiotherapy for early nasopharyngeal carcinoma can improve the patients' quality of life, reduce the radiation injury response and increase the metastasis-free survival rate.
4. Palonosetron combined with dexamethasone prevents nasopharyngeal carcinoma radiotherapy cisplatin-induced nausea and vomiting
Bin LONG ; Jiali SU ; Limin LIU ; Xinhui YANG ; Xiaoyan SHI ; Jun LONG ; Shuliang LI ; Guanghua ZHOU
Chinese Journal of Primary Medicine and Pharmacy 2018;25(17):2197-2202
Objective:
To investigate the efficacy and adverse reactions of palonosetron and dexamethasone in preventing cisplatin-induced nausea and vomiting.
Methods:
From September 2015 to August 2017, a total of 217 nasopharyngeal carcinoma patients in the 163rd Hospital of PLA were randomly divided into two groups according to the digital table.The control group (
5.Comparison of the ECG lead II characteristics in four different species of animals
Ying TAN ; Ming SU ; Wei LIAO ; Xinhui SHI ; Hongbo YANG ; Yong MAO ; Honghua XU ; Tingchuan SHI ; Yong LI ; Ming NA ; Jingkun WANG
Acta Laboratorium Animalis Scientia Sinica 2015;(2):194-198
Objective The ECG lead II characteristics of Beagle dog, rhesus monkey, Japanese white rabbit and tree shrew were analyzed and summarized to provide reference for drug safety evaluation studies.Methods The ECG lead II of healthy adult Beagle dog, rhesus monkey, Japanese white rabbit and tree shrew were recorded to determine the interval of P, PR, QT ( QTc) , the QRS waves and amplitude of P, R, T waves and the ST shift.Results and Conclusion All the animals had sinus rhythm.All the four species of animals had similar ECG pattern with no particular specific changes, but had some differences of the QRS wave group and T wave.The amplitude of P and T waves in Japanese white rabbit was smaller, and the heart rate of tree shrew was faster than that of the other species of animals.The ECG leadⅡdatabase of the Beagle dog, rhesus monkey, Japanese white rabbit and tree shrew is established.
6.Antivirus mechanism of typeⅠinterferon:research progress
Qingzhu SHI ; Zi ZHAO ; Xinhui SHI ; Gencheng HAN
Military Medical Sciences 2015;(7):557-560
Interferon ( IFN) plays an essential role in antiviral infection.Interferons are divided into different categories according to their structure and function.People have attached increasing importance to TypeⅠinterferon( IFN-Ⅰ) in light of its unusual antiviral mechanism.This review is intended to shed light on IFN-Ⅰ,including its antiviral function,signal pathway and regulation.
7.Interaction of anti-thrombotic and anti-inflammatory activities of commonly used traditional Chinese medicine for promoting blood circulation and removing blood stasis revealed by network pharmacology analysis.
Ming Lü ; Taiyi WANG ; Xiaoxuan TIAN ; Xinhui SHI ; Guanwei FAN ; Yan ZHANG ; Yan ZHU
Acta Pharmaceutica Sinica 2015;50(9):1135-41
Chinese traditional patent medicine for promoting blood circulation and removing blood stasis(PBCRBS) originated from traditional Chinese medicine theory and had approved efficacy and safety standards. However, its compatibility regularity and anti-thrombotic mechanism is not clear. To analyze the compatibility regularity and anti-thrombotic mechanism of Chinese traditional patent medicine for PBCRBS, a statistical and bioinformatics analysis was carried out using traditional Chinese medicine inheritance support system (TICMISS, V2.0) and ingenuity pathway analysis (IPA). The compatibility regularity analysis shows that the most commonly used herb combinations are Danshen (Salvia miltiorrhiza Bge.), Chuanxiong (Ligusticum chuanxiong Hort.) and Honghua (Carthamustinctorius L.). The anti-thrombotic mechanism analysis reveals that 25 ingredients have an effect on 29 thrombosis related molecules which 23 molecules are related to inflammation response. Furthermore, there are 5 inflammation molecules (NOS2, PTGS2, IL6, TNF, IL1β) served as major targets. At the same time, Danshen, Chuangxiong and Honghua mainly used as sovereign herb or minister herb in the application of cardiovascular and cerebrovascular diseases. Therefore, Chinese traditional patent medicine for PBCRBS probably has an effect on anti-thrombotic activity through inhibiting the inflammatory response. In summary, the most commonly used herb combinations of Chinese traditional patent medicine for PBCRBS are Danshen, Chuanxiong and Honghua. Inhibiting inflammatory response, especially inflammation related molecules (NOS2, PTGS2, IL6, TNF and IL1β), is probably a new starting point to clarify the anti-thrombotic mechanism of Chinese patent medicine for PBCRBS.
8.The significance of protein SP70 detection for differentiating benign and malignant pleural effusion
Ruixia YANG ; Shiyang PAN ; Fang WANG ; Jian XU ; Peijun HUANG ; Yan ZHANG ; Juan XU ; Yue HAN ; Shanjun ZHU ; Yan CAO ; Peng WANG ; Yuqiao XU ; Jianfang LOU ; Xinhui SHI
Chinese Journal of Laboratory Medicine 2012;(12):1150-1154
Objective To investigate the diagnostic value of detection of protein SP70 in differentiating benign and malignant pleural effusion.Methods A case-control study was conducted from July 2011 to February 2012.108 cases of pleural effusion from patients with clinically proven lung cancers and 122 cases of benign pleural effusion were collected.SP70 was detected by Sandwich ELISA,while CEA,CYFRA21-1,NSE were measured by electrochemiluminescence immunoassay for comparison.Meanwhile,protein SP70 on exfoliated cells in pleural effusion was detected by direct immunofluorescence,and was compared with the results of HE staining.The differences between the groups were evaluated by the chisquare test Fisher' s exact test.Results Positive rates of SP70,CEA,CYFRA21-1,NSE were 72.2%,58.3%,52.8% and 30.6% in malignant pleural effusion,obviously higher than benign pleural effusio (9.8%,13.1%,23.0% and 19.7%).The specificity of SP70,CEA,CYFRA21-1,NSE were 90.2%,86.9%,77.0% and 80.3%,NSCLC had significantly higher positive rate than SCLC(74.3% >0.0%,P =0.02 < 0.05),detection of protein SP70 in malignant pleural effusion had significantly higher coincidence rate than HE staining(72.2% vs 47.2%,x2 =14.03,P < 0.05).Conclusion Determination of the protein SP70 in pleural effusion and in exfoliated cells,can improve the sensitivity and specificity of the diagnosis of malignant pleural effusion.
9.The clinical effect of montelukast combined with budesonide aerosol in the treatment of children with cough variant asthma
Chinese Journal of Primary Medicine and Pharmacy 2012;(24):3699-3700
Objective To observe the clinical efficacy and safety of montelukast combined with budesonide in the treatment of children with cough variant asthma(CVA).Methods 76 cases with CVA were randomly divided into two groups,two groups were treated with terbutaline,discontinuation of the drug after remission of symptoms.38 cases in the observation group were treated with montelukast combined with budesonide,38 cases in the control group were treated with budesonide.All the children were treated for 3 months.The clinical curative effect was compared between the two groups.Follow-up for 6 months,the incidence of adverse reactions and recurrence were observed.Results The total effective rate of observation group was 97.37%,which was higher than that in the control group 86.84%,the difference between the two groups was statistically significant(P<0.05).The adverse reactions occurred in 2 cases(5.26%)of observation group,5 cases(13.16%)in the control group.The incidence of adverse drug reaction rate was slightly lower than that of control group,but the difference was not significant(P>0.05).The observation group had 1 case recurrence(2.63%),the control group 2 cases of recurrence(5.26%),the difference between the two groups was not statistically significant(P>0.05).Conclusion Montelukast combined with budesonide inhalation in treatment of children with CVA has significant efficacy,adverse reactions are mild,low recurrence rate.
10.Low-intensity anticoagulation therapy in the pregnant women with mechanical heart valves:a report with 56 cases
Li DONG ; Xinhui LIU ; Yingkang SHI ; Eryong ZHANG ; Xijun XIAO ; Dan LIU ; Xiao TENG ; Li REN
Chinese Journal of Thoracic and Cardiovascular Surgery 2011;27(1):8-10
Objective To evaluate the method of low-intensity anticoagulation therapy in the pregnant women who had received mechanical heart valve replacemant, and the effects of warfarin on the pregnant women and their fetus. Methods This retrospective study involved 56 pregnant women( 61 pregnancies)who had received mechanical heart valve replacement.Their pregnant status, delivery, and anticoagulation therapy were observed and followed-up between May 1986 and November 2009 at West China Hospital of Sichuan University. Results All patients took oral anticoagulant (warfarin) throughout pregnancy. The dose of domestic warfarin was ( 3.02 ± 0.85 ) mg/d ( in 42 cases), and the dose of imported warfarin was (2.84 ± 0.57 )mg/d (in 14 cases). The mean INR value of 401 samples from patients was 1.67 ±0.58. No thromboembolism or major hemorrhagic complications occurred. Minor bleeding occurred in 11 pregnancies. Forty-seven patients had term delivery, 7 had premature birth, 6 had spontaneous abortion, and 1 had intrauterine fetal death. Six newborns were born with low birth weight (2.3 ± 0. 5 ) kg, and no abnormal fetus was observed. Conclusion The low-intensity anticoagulation therapy with warfarin (at a dose of less than 5 mg/d) and a INR target of 1.5 to 2.0 was safe and convenient for the pregnant women,who had received mechanical heart valve replacement. The abnormalities rate of fetus was low.

Result Analysis
Print
Save
E-mail